Nucleic Acid Labeling Market to Reach $2.5 Billion by 2035

Nucleic acid labeling market was valued at $1.2 billion in 2025 and is projected to reach $2.5 billion by 2035, registering a CAGR of 7.5% during the forecast period. Market growth is primarily driven by the rising global burden of infectious diseases and the increasing demand for advanced molecular diagnostic solutions. According to the World Health Organization, the need for accurate and early disease detection continues to fuel the adoption of nucleic acid–based technologies. These trends are significantly boosting the use of nucleic acid labeling techniques in applications such as PCR, sequencing, and fluorescence in situ hybridization (FISH). Additionally, the expanding focus on precision medicine is contributing to the growing demand for highly sensitive diagnostic tools. The increasing development and commercialization of RNA-based therapeutics further support market expansion. As a result, both research institutions and diagnostic laboratories are rapidly adopting advanced nucleic acid labeling solutions.

Browse the full report description of “Nucleic Acid Labeling Market Size, Share & Trends Analysis Report By Label Type (Radioactive Labeling, Fluorescent Labels, Biotin-based Labels, Digoxigenin (DIG) Labels), By Application (DNA Sequencing, Fluorescence In Situ Hybridization (FISH), Microarrays, PCR & qPCR, Blotting Techniques (Southern/Northern)), By End User (Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Diagnostic Laboratories, Contract Research Organizations (CROs)), and Forecast Period (2026–2035)” at https://www.omrglobal.com/industry-reports/nucleic-acid-labeling-market

Innovation Leaders Transforming the Nucleic Acid Labeling Market

The key players in the nucleic acid labeling market include top companies such as F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific, Danaher Corporation (Cytiva), Merck KGaA, and Agilent Technologies, among others. The market is witnessing steady growth driven by increasing adoption of PCR and sequencing technologies in diagnostics and research. Fluorescent labeling is gaining strong traction due to its safety and sensitivity advantages over radioactive methods. Pharmaceutical and biotechnology companies are expanding investments in RNA research and gene-based therapies. Additionally, advancements in probe design and labeling efficiency are improving experimental accuracy and throughput.

• In September 2025, Promega announced a strategic partnership with Watchmaker Genomics to license a novel engineered reverse transcriptase aimed at enhancing RNA analysis accuracy and sensitivity. The collaboration focuses on advancing molecular analysis capabilities by improving performance in next-generation sequencing and diagnostic applications. This development strengthens Promega’s nucleic acid analysis portfolio, supporting more robust and reproducible workflows in clinical and research settings. The partnership reflects ongoing innovation in enzyme technologies that underpin nucleic acid labeling and related genomic applications.

• In December 2025, Roche the expansion of its molecular diagnostics portfolio, including the launch of multiple new assays and advanced diagnostic solutions across its cobas platforms. These innovations enhance nucleic acid detection capabilities using PCR-based technologies, supporting applications in infectious disease testing and precision medicine.

Market Coverage

• The market number available for – 2025–2035
• Base year- 2025
• Forecast period- 2026–2035
• Segment Covered-
• By Label Type
• By Application
• By End User
• Regions Covered-
• North America
• Europe
• Asia-Pacific
• Rest of the World
• Competitive Landscape: F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific, Danaher Corporation (Cytiva), Merck KGaA, and Agilent Technologies, among others.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Nucleic Acid Labeling Market Report Segment

By Label Type

• Radioactive Labeling
• Fluorescent Labels
• Biotin-based Labels
• Digoxigenin (DIG) Labels

By Application

• DNA Sequencing
• Fluorescence In Situ Hybridization (FISH)
• Microarrays
• PCR & qPCR
• Blotting Techniques (Southern/Northern)

By End User

• Academic & Research Institutes
• Pharmaceutical & Biotechnology Companies
• Diagnostic Laboratories
• Contract Research Organizations (CROs)

Global Nucleic Acid Labeling Market Report Segment by Region

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Russia
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• South Korea
• Australia and New Zealand
• ASEAN Economies
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East & Africa

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/nucleic-acid-labeling-market